Study Details

Back
Study ID 3606-CL-3004
Study Title A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone For Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Clinicaltrials.gov Identifier 01618669
Compound Name CVT3146 / regadenoson
Medical Indication or Disease Myocardial perfusion imaging
Study Sponsor Astellas Pharma Global Development, Inc.(APGD)
Collaborator Gilead Sciences
Study Start Date 29-Jun-2012
Study Completion Date 05-Jun-2014
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS